SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-565996
Filing Date
2016-04-29
Accepted
2016-04-29 07:05:01
Documents
6
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d119408ddefa14a.htm DEFA14A 46151
2 GRAPHIC g119408napg001.jpg GRAPHIC 2265
3 GRAPHIC g119408napg002a.jpg GRAPHIC 2798
4 GRAPHIC g119408napg002b.jpg GRAPHIC 1703
5 GRAPHIC g119408napg003.jpg GRAPHIC 2291
6 GRAPHIC g119408napg004.jpg GRAPHIC 2328
  Complete submission text file 0001193125-16-565996.txt   63695
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Filer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36072 | Film No.: 161602446
SIC: 2834 Pharmaceutical Preparations